Day: July 31, 2026

Pharmacovigilance (PV) & Real-World Data Transforming Drug Safety with Social Media Insights
By Vigilare Biopharma July 31, 2026Pharmacovigilance

Pharmacovigilance (PV) & Real-World Data Transforming Drug Safety with Social Media Insights

A recent article projected that almost 78% of large pharmaceutical companies regularly leverage Artificial Intelligence (AI) to scan social media platforms for drug and side‑effect mentions. It clearly states that Pharmacovigilance (PV) is surpassing traditional

Read More
AI Medical Devices, SaMD Regulations, and 3D-Printed Devices Compliance Challenges for Indian Manufacturers
By Vigilare Biopharma July 31, 2026Medical Devices

AI Medical Devices, SaMD Regulations, and 3D-Printed Devices Compliance Challenges for Indian Manufacturers

In India, there are many AI-based medical devices, SaMD regulations, and 3D‑printed medical devices in the risk-based medical device framework. Rooted in tightened MDR 2017 and emerging CDSCO guidance, however, Indian manufacturers still face major

Read More